List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 37 studies with search of:   "neurofibromatosis type 1"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I
Conditions: Neurofibromatosis Type 1;   Von Recklinghausen Disease;   NF1
Intervention:
2 Active, not recruiting Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Procedure: magnetic resonance imaging
3 Completed Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: pirfenidone
4 Recruiting Sirolimus in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed By Surgery
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: sirolimus
5 Recruiting AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: cediranib maleate
6 Recruiting Sorafenib in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: sorafenib tosylate
7 Recruiting PEG-Interferon Alfa-2b in Treating Young Patients With Unresectable Plexiform Neurofibromas Associated With Neurofibromatosis Type 1
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: PEG-interferon alfa-2b
8 Active, not recruiting Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition;   Sarcoma
Interventions: Drug: placebo;   Drug: tipifarnib
9 Recruiting Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients
Condition: Neurofibromatosis Type 1
Intervention:
10 Active, not recruiting Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: pirfenidone
11 Recruiting Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
Conditions: Neurofibromatosis Type 1;   Tibial Dysplasia
Intervention:
12 Recruiting Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Conditions: Brain and Central Nervous System Tumors;   Neurofibromatosis Type 1 (nf1);   Neurofibromatosis Type 2 (nf2);   Precancerous/Nonmalignant Condition
Intervention: Drug: sunitinib malate
13 Recruiting NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Condition: Neurofibromatosis Type 1
Intervention: Drug: methylphenidate
14 Recruiting Neurobiology and Treatment of Reading Disability in NF-1
Conditions: Neurofibromatosis Type 1;   Reading Disabilities
Interventions: Behavioral: Tutoring Program I;   Behavioral: Tutoring Program II
15 Recruiting Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
Conditions: Dermal Neurofibromas;   Neurofibromatosis Type 1
Intervention:
16 Recruiting Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
Conditions: Neurofibromatosis Type 1 (nf1);   Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: ifosfamide;   Procedure: conventional surgery;   Procedure: radiation therapy
17 Recruiting Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Interventions: Drug: methotrexate;   Drug: vinblastine
18 Recruiting Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Interventions: Drug: fludeoxyglucose F 18;   Drug: gadopentetate dimeglumine;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Procedure: radionuclide imaging
19 Recruiting A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Condition: Neurofibromatosis Type 1
Intervention: Drug: Sirolimus, Rapamycin
20 Recruiting Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
Condition: Neurofibromatosis Type I
Intervention:

Previous Page Studies Shown (1-20) Next (21-37)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services